BOARD OF DIRECTORS
Víctor Grífols Deu
First appointment: 27/05/16
Last appointment: ---
Mr. Víctor Grífols Deu is Grifols' joint and several Chief Executive Officer together with Raimon Grífols Roura since 1 January 2017. He succeeds his father Victor Grífols Roura on the position. He is a member of the administration bodies of several companies within the Grifols Group and was appointed executive director in May 2016. He joined the Group in 2001 as an analyst in the Planning and Control Department. In 2008 he became the director of the Planning and Control Department and was also appointed member of the Executive Committee. He was part of the team that analyzed and was responsible for the integration of the operations of Alpha Therapeutics, Talecris Biotherapeutics and Novartis' Transfusion Diagnostic Unit following the acquisitions.
He holds a degree in Business Administration and Management from the Ramon Llull University – Sarrià Chemical Institute ( IQS) and a postgraduate degree in Business Administration and Management from the Michael Smurfit Business School in Dublin.
Relation with significant shareholders: Víctor Grífols Deu is the grandson of Nuria Roura Carreras (Rodellar Amsterdam Holdings B.V.).
This information is aimed exclusively at authorized healthcare professionals to prescribe or supply medicinal products and its correct interpretation requires specialized training.
Are you a healthcare professional?